© Copyright 2025 American Medical Association. All rights reserved.
The procedure described by CPT® Code 0282T involves the implantation of neurostimulator electrode arrays in a subcutaneous manner, specifically targeting peripheral subcutaneous field stimulation. This technique is utilized to alleviate pain in patients suffering from conditions affecting the cervical, thoracic, or lumbar regions of the spine. Unlike traditional spinal cord stimulation, which targets the central nervous system, peripheral subcutaneous field stimulation focuses on delivering electrical impulses directly to the painful areas just beneath the skin. This method aims to provide localized pain relief by modulating the nerve signals in the affected regions. The procedure is categorized as a trial implantation, which allows for the assessment of the patient's response to the stimulation before any permanent devices are implanted. The trial period typically lasts between 2 to 14 days, during which the effectiveness of the stimulation is evaluated. If the trial proves successful in reducing pain, the patient may then proceed to a permanent implantation of the neurostimulator electrode array and an implantable pulse generator, as described in the subsequent CPT® Code 0283T.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure described by CPT® Code 0282T is indicated for patients experiencing chronic pain localized to the cervical, thoracic, or lumbar regions of the spine. This may include conditions such as neuropathic pain, post-surgical pain, or other pain syndromes that have not responded adequately to conservative treatments. The goal of the procedure is to evaluate the effectiveness of peripheral subcutaneous field stimulation in providing pain relief during a trial period.
The procedure for CPT® Code 0282T involves several key steps to ensure the successful implantation of the neurostimulator electrode array. First, the area of maximal pain is identified and marked on the patient's skin. This is crucial for targeting the most effective site for stimulation. Next, the clinician performs a percutaneous placement of the trial electrode array. An introducer needle is advanced into the subcutaneous tissue at the marked location, utilizing imaging guidance as necessary to ensure accurate placement. Once the needle is in position, an electrode array is threaded through the needle and carefully positioned within the subcutaneous tissue of the target area. The correct positioning of the electrode array is then verified using fluoroscopic imaging to confirm that it is optimally placed for effective stimulation.
After the procedure, patients are monitored for any immediate complications related to the implantation. The trial electrode array is left in place for a specified duration, typically between 2 to 14 days, during which the effectiveness of the stimulation is assessed. Patients are advised to keep the area clean and dry, and to report any unusual symptoms such as increased pain, swelling, or signs of infection. Following the trial period, the clinician will evaluate the patient's response to the stimulation. If there is a significant reduction in pain, the patient may be considered for a subsequent procedure involving the permanent implantation of the neurostimulator electrode array and an implantable pulse generator. This decision will be based on the documented effectiveness of the trial stimulation in alleviating the patient's pain.
Short Descr | PERIPH FIELD STIMUL TRIAL | Medium Descr | PERC/OPEN IMPLNT NEUROSTIM ELECTRODE SUBQ TRIAL | Long Descr | Percutaneous or open implantation of neurostimulator electrode array(s), subcutaneous (peripheral subcutaneous field stimulation), including imaging guidance, when performed, cervical, thoracic or lumbar; for trial, including removal at the conclusion of trial period | Status Code | Carriers Price the Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 0 - No payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 1 - 150% payment adjustment for bilateral procedures applies. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Hospital Part B services paid through a comprehensive APC | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | T2D - Other tests - other | MUE | Not applicable/unspecified. | CCS Clinical Classification | 9 - Other OR therapeutic nervous system procedures |
Date
|
Action
|
Notes
|
---|---|---|
2017-01-01 | Changed | Moderate (Conscious) Sedation flag removed. See new Moderate Sedation category. |
2016-12-31 | Deleted | Code deleted. |
2012-01-01 | Added | Added |
Get instant expert-level medical coding assistance.